Brookfield Corp’s AbbVie ABBV Stock Holding History

Brookfield Corp’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-90,875	Closed	-$12.2M	–	108
2023 Q2	$12.2M	Sell	90,875 -186,673	-67%	-$27.4M	0.05%	139
2023 Q1	$44.2M	Buy	277,548 +200,077	+258%	+$30.6M	0.17%	61
2022 Q4	$12.5M	Sell	77,471 -78,780	-50%	-$12.1M	0.05%	132
2022 Q3	$21M	Buy	+156,251	New	+$22.4M	0.08%	94
2022 Q2	–	Sell	-69,609	Closed	-$11.3M	–	579
2022 Q1	$11.3M	Sell	69,609 -37,268	-35%	-$5.41M	0.04%	139
2021 Q4	$14.5M	Buy	106,877 +56,921	+114%	+$6.72M	0.06%	100
2021 Q3	$5.39M	Buy	49,956 +31,790	+175%	+$3.63M	0.02%	208
2021 Q2	$2.05M	Buy	+18,166	New	+$2.05M	0.01%	351

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return